
201 - 500 employees
Founded 2015
🧬 Biotechnology
🏥 Healthcare
💊 Pharmaceuticals
💰 $140M Post-IPO Equity - Replimune Group on 2024-11
Biotechnology • Healthcare • Pharmaceuticals
Replimune is a clinical-stage biotechnology company focused on developing a new class of oncolytic immunotherapies intended to activate powerful, durable systemic anti-tumor immune responses. The company’s approach is to kill tumors locally, alter the tumor microenvironment, and ignite a full-body, tumor-specific immune response. Replimune is conducting clinical programs evaluating the safety and effectiveness of its investigational therapies in a range of solid tumors, both as single agents and in combination with other immunotherapies.
Selected: 🆕 Date Added.
🕒 Yesterday
Regional Medical Science Liaison director leading field medical strategy and MSL teams. Supporting Replimune’s oncolytic immunotherapy development and cancer-care mission.
🍂 Massachusetts – Remote
💵 $256k - $331k / year
💰 $140M Post-IPO Equity - Replimune Group on 2024-11
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 0%
🕒 August 28
Operational Excellence Lead helping U.S. treatment centers adopt Replimune’s RP1 cancer therapy. Optimizing workflows, readiness, logistics, and multidisciplinary care coordination.
🍂 Massachusetts – Remote
💵 $170k - $218k / year
💰 $140M Post-IPO Equity - Replimune Group on 2024-11
⏰ Full Time
🟠 Senior
⚙️ Operations
👻 Ghost score 0%
🕒 August 28
Medical Information Director advancing Replimune’s oncolytic cancer immunotherapies. Leading scientific communications, launch support, regulatory review, and cross-functional Medical Affairs operations.
🍂 Massachusetts – Remote
💵 $208.5k - $265.5k / year
💰 $140M Post-IPO Equity - Replimune Group on 2024-11
⏰ Full Time
🔴 Lead
👨⚕️ Medical Director
👻 Ghost score 0%
🕒 August 28
Strategic Account Manager launching Replimune’s innovative melanoma therapy. Developing oncology account strategies and improving patient access across multidisciplinary treatment centers.
🍂 Massachusetts – Remote
💵 $183k - $237k / year
💰 $140M Post-IPO Equity - Replimune Group on 2024-11
⏰ Full Time
🟠 Senior
💰 Account Manager
👻 Ghost score 0%
🕒 August 26
Strategic Account Manager advancing Replimune’s oncolytic cancer immunotherapies. Guiding oncology accounts, reimbursement, patient access, and treatment adoption.
🍂 Massachusetts – Remote
💵 $183k - $237k / year
💰 $140M Post-IPO Equity - Replimune Group on 2024-11
⏰ Full Time
🟠 Senior
💰 Account Manager
👻 Ghost score 0%
🕒 August 19
Strategic Account Manager launching Replimune’s innovative melanoma therapy. Developing oncology account strategies and improving patient access across multidisciplinary treatment centers.
🍂 Massachusetts – Remote
💵 $183k - $237k / year
💰 $140M Post-IPO Equity - Replimune Group on 2024-11
⏰ Full Time
🟠 Senior
💰 Account Manager
👻 Ghost score 0%
🕒 August 19
Strategic Account Manager launching Replimune’s innovative melanoma therapy. Developing oncology account strategies, coordinating multidisciplinary care, and expanding patient access across treatment centers.
🍂 Massachusetts – Remote
💵 $183k - $237k / year
💰 $140M Post-IPO Equity - Replimune Group on 2024-11
⏰ Full Time
🟠 Senior
💰 Account Manager
👻 Ghost score 0%
🕒 August 18
Strategic Account Manager launching Replimune’s innovative oncology therapy for advanced melanoma. Developing account strategies, improving patient access, and partnering with multidisciplinary cancer-care teams.
🍂 Massachusetts – Remote
💵 $183k - $237k / year
💰 $140M Post-IPO Equity - Replimune Group on 2024-11
⏰ Full Time
🟠 Senior
💰 Account Manager
👻 Ghost score 0%
🕒 July 28
Senior Medical Science Liaison responsible for developing relationships with oncology thought leaders. Assist in management of investigator studies and support Replimune's clinical development initiatives.
🍂 Massachusetts – Remote
💵 $208.5k - $269.5k / year
💰 $140M Post-IPO Equity - Replimune Group on 2024-11
⏰ Full Time
🟠 Senior
✨ Medical Science Liaison
👻 Ghost score 2%